New Report
Best Biotechnology and Pharmaceutical Investing Interviews of 2012
November 26, 2012
» See all the topics and companies covered
-
Long-Term, Value-Oriented Approach in Risky Macro Environment - Robert Joseph Sanborn - Sanborn Kilcollin Partners, LLC
Robert Joseph Sanborn - Sanborn Kilcollin Partners, LLC
-
Hospital Volumes are Stabilizing Amidst Reimbursement Uncertainties
Thomas Gallucci
-
Pockets of Organic Growth in Health Care as Stability Trudges
Kevin Ellich
-
Medical Device Opportunities in the Chinese Middle Class
Jason Mann
-
Higher-Efficiency Plays in Research and Diagnostics Despite Bearish Sentiments
Amit Bhalla
-
Emerging-Growth Opportunities in Oncology Biotech
Boris Peaker
-
Monetizing Price Discrepancies in Health Care Equities
Paul Nouri
-
Hepatitis C Therapies Propel Growth in Biotech
Matthew Roden
-
U.S. Biotech Valuations Appear Attractive Despite Earlier Run
Jim Birchenough
-
Demographics Favor More and Quicker Adoption of Private-Sector Solutions
Thomas Carroll










